Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from FDA

Lawmakers strike deal on 'practically clean' FDA user fee bill - Roll Call

The reauthorization is expected to hitch a ride on the short-term government funding bill Congress is expected to take up next week.

Roll Call

Warning over dangerous 'sleepy chicken' social media challenge using cough medicine

Known as the "sleepy chicken" challenge, health chiefs have warned that the viral trend is dangerous and could even cause death.

Daily Record

Breast cancer risk due to implants explained as FDA warns about potential link

Breast cancer and breast implants link has been shrouded with anecdotal doubts and theories. Recently, the Food and Drug Administration has issued a statement pertaining to this

Daily Mirror

From analysis to the latest developments in health,
read the most diverse news in one place.

Please don't cook chicken in NyQuil, the FDA asks TikTok users

The challenge, which originated in part from a 2017 Twitter joke, is the subject of an FDA warning about unhealthy cooking challenges from TikTok.

WEKU

FDA reminds people not to cook chicken in Nyquil after ‘dangerous’ TikTok trend resurfaces

‘These video challenges, which often target youths, can harm people — and even cause death,’ the agency said

The Independent UK

Food industry wary of mandates ahead of hunger conference

WASHINGTON — The food industry is hoping that changes in its market in the past five decades will persuade the Biden administration and Congress to tread lightly as they consider new mandates on the sector.

Tribune News Service

'This Is Not a Bluff': Putin Amps Up Nuke Threats

Plus: Migrants sue DeSantis, Justice Department undercounts jail and prison deaths, Juul sues for FDA records, and more...

Reason

Read news from The Economist, FT, and more,
with one subscription

Top Financial Media Stories Wednesday, September 21: Amazon's Roomba Maker Acquisition Attracts Regulatory Attention, Binance And FTX Bid For Voyager Digital's Assets, Germany Nationalizes Gas Giant Uniper To Avert Energy Crisis And More..

Wall Street Journal

Benzinga

IGC Announces Issuance Of Second Patent For The Treatment Of Alzheimer's Using THC

India Globalization Capital, Inc. (AMEX:IGC) announced that the United States Patent and Trademark Office issued a second patent (#11,446,276) for the treatment of Alzheimer’s disease entitled “Extreme low dose THC as a therapeutic and prophylactic agent for Alzheimer’s disease.”

Benzinga

Food industry wary of mandates ahead of hunger conference - Roll Call

As the administration prepares for its Sept. 28 hunger conference, the food industry is wary of new labeling mandates.

Roll Call

FDA seems poised to approve a new drug for ALS, but does it work?

In March, experts who advise the FDA questioned the efficacy of an experimental new drug for ALS. In September, they voted to approve it anyway.

WEKU

FDA warns cooks about "NyQuil Chicken"

TikTok users are apparently bringing to cold and flu medicine into the kitchen, with potentially poisonous results

Salon

Don’t cook your chicken in Nyquil, FDA warns after viral social media trend resurfaces

“These video challenges, which often target youths, can harm people — and even cause death,” the agency said.

The Independent UK

FDA concedes delays in response to baby formula shortage

U.S. health regulators say their response to the ongoing infant formula shortage was slowed by delays in processing a whistleblower complaint and test samples from the nation’s largest formula factory

The Independent UK

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

FDA Says No Way To Food Companies Wanting To Get On The CBD Gravy Train

As several major food makers are champing at the bit to cash in on the CBD food and drinks craze, it seems the FDA is still not down with the program.

StockNews.com

3 Healthcare Stocks Under $100 to Buy Right Now

The rising prevalence of chronic diseases and the aging population are major growth drivers for the healthcare industry. In addition, increased investments in technological advancements should further bolster the industry’s growth. Thus, we think it may be prudent to buy quality healthcare stocks Pfizer Inc. (PFE), Merck & Co. (MRK),…

Benzinga

Dow Dips 400 Points; Ford Shares Slide

U.S. stocks traded lower toward the end of trading, with the Dow Jones dropping 400 points on Tuesday.

Benzinga

Nasdaq Down 50 Points; Crude Oil Falls Sharply

U.S. stocks traded lower midway through trading, with the Nasdaq Composite dropping around 50 points on Tuesday.

Get all your
news in one place.

100’s of premium titles.
One news app.

WEKU

Family Dollar recalls Colgate products that were improperly stored

Family Dollar says it is not aware of any complaints from customers nor any reports of illnesses related to the recall.

The Hindu

PSI suspended for allegedly promising govt. job in return for bribe

MYSURU

Tribune News Service

Bluebird’s gene therapy for brain disease receives accelerated approval

Bluebird Bio Inc.’s gene therapy for a brain-wasting disease received accelerated approval from U.S. regulators, making it the first treatment of its kind for children living with cerebral adrenoleukodystrophy.

The Hindu

Congress releases audio of alleged scam in FDA recruitment

MYSURU

Benzinga

FDA Okays bluebird bio's $3M Gene Therapy For Rare Neurological Disorder In Boys: What Investors Should Know

Biotechnology company, bluebird bio, Inc. (NASDAQ: BLUE) announced late Friday that the Food and Drug Administration approved its gene therapy for a rare neurodegenerative disease.

The Hindu

Maharashtra FDA cancels Johnson & Johnson's baby powder manufacturing licence

The State government agency said the company's product, Johnson's Baby Powder, may affect the skin of newborn babies

StockNews.com

1 Stock That’ll Make You Turn Blue in the Face for Owning

Biotech company bluebird bio (BLUE) received FDA approval for ZYNTEGLO last month, which seems to have boosted its stock price. However, given its bleak profitability and stretched valuations, the stock might be best avoided. Read on….

1 … 163 164 165 166

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Bharatiya Janata Party

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.